Raia Drogasil dividend and valuation
Valuation
Raia Drogasil paid R$0.45 per share in dividends over the last 12 months (yield 3.3%). Last ex-dividend date: October 8, 2026. The P/E ratio is 17.6. The average price target of 15 analysts is R$23.37.
What would Raia Drogasil's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 20, 2026
Raia Drogasil compared with similar companies
Raia Drogasil's P/E (trailing 12 months): 17.6, +22% against the median of a group of 10 similar companies (14.4).
| Metric | Raia Drogasil | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 17.6 | 14.4 | 11.3 – 17.5 | High |
| Forward P/E | 12.5 | 12.5 | 10.4 – 14.0 | Middle |
| EV/EBITDA | 8.45 | 8.45 | 6.07 – 11.1 | Middle |
| Price/book | 3.18 | 1.87 | 1.14 – 1.99 | High |
| Price/sales | 0.51 | 0.40 | 0.29 – 0.58 | Middle |
| Gross margin | 30.9% | 24.0% | 20.9% – 28.7% | High |
| Operating margin | 6.1% | 5.6% | 5.0% – 6.5% | Middle |
| Net margin | 2.7% | 2.7% | 1.9% – 4.8% | Middle |
| ROE | 19.7% | 11.3% | 7.6% – 16.9% | High |
| Debt/equity | 1.17 | 0.78 | 0.29 – 1.09 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same and related industries, similar size
Raia Drogasil: valuation over time
On the latest fiscal year's earnings (2025), Raia Drogasil's P/E today is 17.5, below the median of its last 10 fiscal years (46.2; between 30.0 and 85.5 from 2016 to 2025). Relative to earnings, the stock costs less than it used to. The dividend yield (3.3%) is in line with the median of the last 6 fiscal years (3.3%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | R$23.45 | R$0.78 | 30.0 | R$0.39 | 1.7% |
| 2024 | R$21.57 | R$0.71 | 30.3 | — | — |
| 2023 | R$28.82 | R$0.61 | 47.2 | R$0.21 | 0.7% |
| 2022 | R$22.36 | R$0.57 | 39.4 | — | — |
| 2021 | R$22.91 | R$0.43 | 53.4 | — | — |
| 2020 | R$23.60 | R$0.28 | 85.5 | — | — |
| 2019 | R$21.05 | R$0.44 | 47.8 | R$0.64 | 3.0% |
| 2018 | R$10.77 | R$0.29 | 37.5 | R$0.64 | 5.9% |
| 2017 | R$17.31 | R$0.29 | 59.3 | R$0.61 | 3.5% |
| 2016 | R$11.54 | R$0.26 | 45.1 | R$0.59 | 5.1% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- R$23.99B
- Enterprise value
- R$32.2B
- PEG
- 0.27
- EV/revenue
- 0.68
Profitability and growth
- ROA
- 7.3%
- ROIC
- 11.4%
- Revenue growth (year over year)
- 7.8%
- Earnings growth (year over year)
- -8.8%
Financial health
- Total cash
- R$627.2M
- Total debt
- R$8.83B
- Current ratio
- 1.40
- Quick ratio
- 0.47
- Altman Z-Score
- 3.78
- Piotroski F-Score
- 7.00
Dividends
- Annual dividend per share
- R$0.45
- Dividend yield
- 3.3%
- Payout ratio
- 57.8%
- Ex-dividend date
- October 8, 2026
Analysts and estimates
- Average price target
- R$23.37
- Median price target
- R$25.00
- High price target
- R$28.00
- Low price target
- R$15.00
- Analysts with a price target
- 15
- Consensus
- Buy
- Forward EPS
- R$1.10
- EPS estimate, current year
- R$0.88
Shares and trading
- Beta
- 0.08
- Average volume
- 12.61M
- Shares outstanding
- 1.75B
- Float
- 1.3B
- Institutional ownership
- 53.3%
- Insider ownership
- 25.3%
